Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Research in Pharmacy is Scopus-indexed (Q3, CiteScore 1.3), WoS ESCI. Published by Marmara University.
Checked against the index lists dated .
ISSN 2630-6344Verify ISSN ↗
Publisher: Marmara University
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 54 / 79 | 32nd | Q3 |
| Pharmacology (medical) | 206 / 278 | 26th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.3.
Journal of Research in Pharmacy is Q3 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 54 of 79) and Q3 in Pharmacology (medical) (rank 206 of 278), by CiteScore 2025.
Journal of Research in Pharmacy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q3 at the 32nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.202, quartile Q3, with an H-index of 26.
Journal of Research in Pharmacy is published by Marmara University. Its ISSN is 2630-6344.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Research in Pharmacy has an h-index of 19 and a 2-year mean of 0.9 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #48 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Journal of Research in Pharmacy published 234 papers in 2025; its busiest recent year was 2023 with 359. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from Türkiye (45.1%), Indonesia (20.3%) and India (8.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.